BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9387959)

  • 1. Mucociliary clearance in cystic fibrosis knockout mice infected with Pseudomonas aeruginosa.
    Cowley EA; Wang CG; Gosselin D; Radzioch D; Eidelman DH
    Eur Respir J; 1997 Oct; 10(10):2312-8. PubMed ID: 9387959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.
    van Heeckeren AM; Schluchter MD; Drumm ML; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L944-52. PubMed ID: 15246977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
    Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
    Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
    Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets.
    Caballero I; Ringot-Destrez B; Si-Tahar M; Barbry P; Guillon A; Lantier I; Berri M; Chevaleyre C; Fleurot I; Barc C; Ramphal R; Pons N; Paquet A; Lebrigand K; Baron C; Bähr A; Klymiuk N; Léonard R; Robbe-Masselot C
    J Cyst Fibros; 2021 Jan; 20(1):173-182. PubMed ID: 32978064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung.
    Hvorecny KL; Dolben E; Moreau-Marquis S; Hampton TH; Shabaneh TB; Flitter BA; Bahl CD; Bomberger JM; Levy BD; Stanton BA; Hogan DA; Madden DR
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L150-L156. PubMed ID: 28982736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.
    Brockman SM; Bodas M; Silverberg D; Sharma A; Vij N
    PLoS One; 2017; 12(9):e0184793. PubMed ID: 28902888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.
    Gosselin D; Stevenson MM; Cowley EA; Griesenbach U; Eidelman DH; Boulé M; Tam MF; Kent G; Skamene E; Tsui LC; Radzioch D
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1253-62. PubMed ID: 9563748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology.
    Larbig M; Jansen S; Dorsch M; Bernhard W; Bellmann B; Dorin JR; Porteous DJ; Von Der Hardt H; Steinmetz I; Hedrich HJ; Tuemmler B; Tschernig T
    Pathobiology; 2002-2003; 70(2):89-97. PubMed ID: 12476034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
    Laube BL; Sharpless G; Benson J; Carson KA; Mogayzel PJ
    J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia.
    Cho DY; Zhang S; Skinner DF; Lim DJ; Banks C; Grayson JW; Tearney GJ; Rowe SM; Woodworth BA
    Int Forum Allergy Rhinol; 2022 May; 12(5):690-698. PubMed ID: 34704673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells.
    Trinh NT; Bilodeau C; Maillé É; Ruffin M; Quintal MC; Desrosiers MY; Rousseau S; Brochiero E
    Eur Respir J; 2015 Jun; 45(6):1590-602. PubMed ID: 25792634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
    Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.
    van Heeckeren AM; Schluchter M; Xue L; Alvarez J; Freedman S; St George J; Davis PB
    Infect Immun; 2004 Mar; 72(3):1479-86. PubMed ID: 14977953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung arginase expression and activity is increased in cystic fibrosis mouse models.
    Jaecklin T; Duerr J; Huang H; Rafii M; Bear CE; Ratjen F; Pencharz P; Kavanagh BP; Mall MA; Grasemann H
    J Appl Physiol (1985); 2014 Aug; 117(3):284-8. PubMed ID: 24925982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections.
    Pier GB
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8822-8. PubMed ID: 10922041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.